Mar 18, 2021 8:30am EDT Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
Mar 09, 2021 8:30am EST Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position
Mar 08, 2021 8:30am EST Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference
Mar 01, 2021 8:30am EST Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
Jan 26, 2021 9:00am EST Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China
Jan 05, 2021 9:00am EST Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
Dec 18, 2020 3:07pm EST Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
Dec 16, 2020 10:25am EST Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering
Dec 15, 2020 9:00am EST Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology
